Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

324.71 +0.48 (+0.15%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
21 22 Next >
Can COVID-19 Antibody Treatment Help In High-Risk Cases? Mayo Clinic, nference Study Shows Potential
Mayo Clinic and nference are jointly conducting artificial intelligence-powered studies evaluating monoclonal antibodies for COVID-19 in patients with an elevated risk... 
Via Benzinga
Exposures COVID-19
Where Eli Lilly Stands With Analysts
Analysts have provided the following ratings for Eli Lilly (NYSE:LLY) within ... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Edge Higher After S&P 500, Nasdaq Hit Record Highs
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade after the S&P and the Nasdaq hit record closing highs in the previous session following... 
Via Benzinga
Topics Stocks
Exposures US Equities
Distribution Resumes Of Eli Lilly COVID-19 Antibody Therapies
After the US paused distribution of Eli Lilly And Co's COVID-19 antibody therapies in June, the pharmaceutical company says those therapies are once again being distributed. 
Via Talk Markets
Exposures COVID-19
Distribution Resumes Of Eli Lilly COVID-19 Antibody Therapies
After the US paused distribution of Eli Lilly And Co (NYSE: LLY)'s COVID-19 antibody therapies in June, the pharmaceutical company says those therapies are once again being... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
Unusual Options Activity Insight: Eli Lilly
On Wednesday, shares of Eli Lilly (NYSE:LLY) saw unusual opt... 
Via Benzinga
Here's What This Label Expansion Could Mean for Eli Lilly Investors
The pharmaceutical company's type 2 diabetes drug Jardiance was recently approved by the FDA for another indication. 
Via The Motley Fool
Exposures Product Safety
Eli Lilly, Boehringer Share Jardiance Data In Heart Failure Field
Eli Lilly And Co (NYSE: LLY) and Boehringer Ingelheim have rolled out full results of EMPEROR-Preserved phase 3 trial of Jardiance (empagliflozin) for heart... 
Via Benzinga
This Potential Indication Could Mean Profit for Eli Lilly Investors
Eli Lilly updated investors on its ongoing phase 3 trials to treat patients who have moderate to severe eczema with a new drug. 
Via The Motley Fool
3 Big Drug/Biotech Outperformers Worth Keeping an Eye On
The second-quarter earnings season was a strong one for the drug/biotech sector. 
Via Talk Markets
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Exposures COVID-19
Friday Fears and Other Stock News Updates
Toyota has cut its output 40% over fear of the Delta variant of Covid, plus shortages of electronics. This is terrifying markets outside the USA. And other global stock news updates. 
Via Talk Markets
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues,... 
Via Benzinga
Exposures Product Safety
4 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
FDA Approves Eli Lilly's Jardiance For Heart Failure
The FDA approves Eli Lilly And Co (NYSE: LLY) - Boehringer Ingelheim's Jardiance (empagliflozin) 10 mg for heart failure. The approval comes to... 
Via Benzinga
Exposures Product Safety
Advancement in Connectivity Technology Expected to Enhance the Growth of the Biosimilars Market During the Projected Period 2021-2027
Advancement in Connectivity Technology Expected to Enhance the Growth of the Biosimilars Market during the Projected Period 2021-2027 
Via SBWire
Topics Economy
Exposures COVID-19 Economy
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs. Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market cap to set a new 52-week... 
Via Benzinga
Eli Lilly Stock Soars To 96 Composite Rating
Eli Lilly saw its IBD SmartSelect Composite Rating rise to 96 Monday, up from 94 the day before. 
Via Investor's Business Daily
FDA Clears Use Of Eli Lilly's Insulin With Insulet's Infusion Pumps
The 
Via Benzinga
Exposures Product Safety
Innovent's Sintilimab/Chemo Regime Shows Overall Survival Benefit In Gastric Cancer
Innovent Biologics Inc (OTC: IVBIY) has announced topline results from Phase 3 ORIENT-16 study evaluating sintilimab, meeting the primary endpoint of overall... 
Via Benzinga
Lilly's Lebrikizumab Shows Clinical Benefit In Late-Stage Atopic Eczema Trials
Eli Lilly And Co's (NYSE: LLY) lebrikizumab ADvocate 1 and ADvocate 2 Phase 3 clinical trials met primary and all key secondary endpoints at Week 16. ... 
Via Benzinga
Why AbCellera Biologics Stock Was Up More Than 17% on Friday
The biopharma company's second quarter was better than expected. The future looks pretty bright, too. 
Via The Motley Fool
Lung Cancer Drugs Market 2021: (COVID-19 UPDATE) Future Challenges and Industry Growth Outlook : AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company
Lung Cancer Drugs Market : Global Opportunity Analysis and Industry Forecast, 2021–2027 
Via SBWire
Exposures COVID-19
Vaccine Stocks Fly On Booster Shot OK, But Their Run Could Be Short-Lived
Vaccine stocks popped Friday after the FDA authorized a third dose of their Covid shots from some immunocompromised people. 
Via Investor's Business Daily
Exposures Product Safety
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
3 Pharma Stocks to Buy in August
These stocks offer solid growth opportunities. 
Via The Motley Fool
Women's Health Care Market Worth $17.8 Billion – Growing Prevalence of PCOS and Obesity to Support Growth in Canada
The global women’s healthcare market is projected to reach USD 17.8 billion by 2024 from USD 9.6 billion in 2019, at a CAGR of 13.2% during the forecast period 
Via SBWire
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.